EGFRvIII mediates RIP1 K63 ubiquitination while RIP1 interacts with NEMO and TAK1 to activate NF-κB, which modulates tumorigenesis and efficacy of targeted treatment in GBM [192]. Here, IKBKG is linked to glioblastoma.